Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Is it time to recognize a new phenotype? Heart failure with preserved ejection fraction with pulmonary vascular disease.

Literature DB >> 28431020

Is it time to recognize a new phenotype? Heart failure with preserved ejection fraction with pulmonary vascular disease.

Barry A Borlaug¹, Masaru Obokata¹.

Abstract

Entities: Disease

Mesh：

Year: 2017 PMID： 28431020 PMCID： PMC7190896 DOI： 10.1093/eurheartj/ehx184

Source DB: PubMed Journal: Eur Heart J ISSN： 0195-668X Impact factor: 29.983

× No keyword cloud information.

36 in total

1. Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction.

Authors: Barry A Borlaug; Garvan C Kane; Vojtech Melenovsky; Thomas P Olson
Journal: Eur Heart J Date: 2016-06-26 Impact factor: 29.983

2. Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study.

Authors: Marco Guazzi; Marco Vicenzi; Ross Arena; Maurizio D Guazzi
Journal: Circulation Date: 2011-06-27 Impact factor: 29.690

3. Differential hemodynamic effects of exercise and volume expansion in people with and without heart failure.

Authors: Mads J Andersen; Thomas P Olson; Vojtech Melenovsky; Garvan C Kane; Barry A Borlaug
Journal: Circ Heart Fail Date: 2014-10-23 Impact factor: 8.790

4. Pulmonary hypertension is related to peripheral endothelial dysfunction in heart failure with preserved ejection fraction.

Authors: Marta Farrero; Isabel Blanco; Montserrat Batlle; Evelyn Santiago; Montserrat Cardona; Barbara Vidal; M Angeles Castel; Marta Sitges; Joan Albert Barbera; Felix Perez-Villa
Journal: Circ Heart Fail Date: 2014-07-21 Impact factor: 8.790

5. Acute hemodynamic effects of inhaled sodium nitrite in pulmonary hypertension associated with heart failure with preserved ejection fraction.

Authors: Marc A Simon; Rebecca R Vanderpool; Mehdi Nouraie; Timothy N Bachman; Pamela M White; Masataka Sugahara; John Gorcsan; Ed L Parsley; Mark T Gladwin
Journal: JCI Insight Date: 2016-11-03

6. Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure.

Authors: Juan F Delgado; Esther Conde; Violeta Sánchez; Fernando López-Ríos; Miguel A Gómez-Sánchez; Pilar Escribano; Teresa Sotelo; Agustín Gómez de la Cámara; José Cortina; Carlos S de la Calzada
Journal: Eur J Heart Fail Date: 2005-10 Impact factor: 15.534

7. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study.

Authors: Carolyn S P Lam; Véronique L Roger; Richard J Rodeheffer; Barry A Borlaug; Felicity T Enders; Margaret M Redfield
Journal: J Am Coll Cardiol Date: 2009-03-31 Impact factor: 24.094

8. Prognostic role of pulmonary arterial capacitance in advanced heart failure.

Authors: Matthias Dupont; Wilfried Mullens; Hadi N Skouri; Zuheir Abrahams; Yuping Wu; David O Taylor; Randall C Starling; W H Wilson Tang
Journal: Circ Heart Fail Date: 2012-10-18 Impact factor: 8.790

9. Diagnosis, Treatment, and Clinical Management of Pulmonary Arterial Hypertension in the Contemporary Era: A Review.

Authors: Bradley A Maron; Nazzareno Galiè
Journal: JAMA Cardiol Date: 2016-12-01 Impact factor: 14.676

10. Hemodynamic evidence of vascular remodeling in combined post- and precapillary pulmonary hypertension.

Authors: Tufik R Assad; Evan L Brittain; Quinn S Wells; Eric H Farber-Eger; Stephen J Halliday; Laura N Doss; Meng Xu; Li Wang; Frank E Harrell; Chang Yu; Ivan M Robbins; John H Newman; Anna R Hemnes
Journal: Pulm Circ Date: 2016-09 Impact factor: 3.017

19 in total

Review 1. The Role of Echocardiography in Heart Failure with Preserved Ejection Fraction: What Do We Want from Imaging?

Authors: Masaru Obokata; Yogesh N V Reddy; Barry A Borlaug
Journal: Heart Fail Clin Date: 2019-02-02 Impact factor: 3.179

2. Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease.

Authors: Thomas M Gorter; Masaru Obokata; Yogesh N V Reddy; Vojtech Melenovsky; Barry A Borlaug
Journal: Eur Heart J Date: 2018-08-07 Impact factor: 29.983

3. The β-Adrenergic Agonist Albuterol Improves Pulmonary Vascular Reserve in Heart Failure With Preserved Ejection Fraction.

Authors: Yogesh N V Reddy; Masaru Obokata; Katlyn E Koepp; Alexander C Egbe; Brandon Wiley; Barry A Borlaug
Journal: Circ Res Date: 2019-01-18 Impact factor: 17.367

Review 4. Performance and Interpretation of Invasive Hemodynamic Exercise Testing.

Authors: C Charles Jain; Barry A Borlaug
Journal: Chest Date: 2020-05-28 Impact factor: 9.410

5. Haemodynamics, dyspnoea, and pulmonary reserve in heart failure with preserved ejection fraction.

Authors: Masaru Obokata; Thomas P Olson; Yogesh N V Reddy; Vojtech Melenovsky; Garvan C Kane; Barry A Borlaug
Journal: Eur Heart J Date: 2018-08-07 Impact factor: 29.983

6. The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction.

Authors: Masaru Obokata; Garvan C Kane; Yogesh N V Reddy; Vojtech Melenovsky; Thomas P Olson; Petr Jarolim; Barry A Borlaug
Journal: Eur Heart J Date: 2019-12-01 Impact factor: 29.983

7. Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction.

Authors: Masaru Obokata; Yogesh N V Reddy; Vojtech Melenovsky; Sorin Pislaru; Barry A Borlaug
Journal: Eur Heart J Date: 2019-02-21 Impact factor: 29.983